Literature DB >> 16934456

N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors.

Hong Nie1, Katherine L Widdowson, Michael R Palovich, Wei Fu, John D Elliott, Deborah L Bryan, Miriam Burman, Dulcie B Schmidt, James J Foley, Henry M Sarau, Jakob Busch-Petersen.   

Abstract

A series of N-(2-hydroxy-3-sulfonamidobenzene)-N'-arylcyanoguanidines was prepared. In general, these compounds proved to be potent antagonists of CXCR2 while the selectivity versus CXCR1 ranged from non-selective to >200-fold.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934456     DOI: 10.1016/j.bmcl.2006.08.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Authors:  Helen Ha; Bikash Debnath; Nouri Neamati
Journal:  Theranostics       Date:  2017-04-07       Impact factor: 11.556

2.  Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents.

Authors:  Jinxin Che; Zhilong Wang; Haichao Sheng; Feng Huang; Xiaowu Dong; Youhong Hu; Xin Xie; Yongzhou Hu
Journal:  R Soc Open Sci       Date:  2018-07-04       Impact factor: 2.963

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.